Zydus Told To Conduct Phase III Trial in India for Lurbinectedin Injection, BE Study Waived Parthika Patel31 July 2025 1:49 PM ISTNew Delhi: Zydus Lifesciences Limited has been directed to conduct a Phase III clinical trial in the Indian population for its proposed oncology drug...
Roche Slammed for Seeking Zydus' Confidential Process for Cancer Drug Sigrima Without Meeting Patent Threshold Farhat Nasim28 July 2025 6:29 PM ISTNew Delhi: In a major relief to Zydus Lifesciences, the Delhi High Court dismissed F. Hoffmann-La Roche's plea seeking disclosure of Zydus'...
Delhi HC Bars Zydus From Launching Cancer Drug Nivolumab Biosimilar Till 2026 Farhat Nasim23 July 2025 4:45 PM ISTNew Delhi: In a major setback to Zydus Lifesciences, the Delhi High Court has restrained the company from launching its proposed biosimilar of the...
Ichnos Glenmark Innovation, AbbVie ink pact for investigational cancer drug Ruchika Sharma11 July 2025 2:54 PM ISTNew York: AbbVie and IGI Therapeutics SA, a wholly owned subsidiary of New York-based Ichnos Glenmark Innovation, Inc. (IGI), have announced an...
Bombay HC Notice to CDSCO on Denial of Phase I Trial for Indigenous Cancer Drug Farhat Nasim12 May 2025 6:07 PM ISTMumbai: The Bombay High Court has issued a notice to the Central Drugs Standard Control Organisation (CDSCO) and the Union government following a...
CDSCO Panel Approves AstraZeneca's Protocol Amendment for Anti-cancer Drug AZD0901 study Dr. Divya Colin4 May 2025 5:45 PM ISTNew Delhi: The Subject Expert Committee (SEC), functional under the Central Drug Standard Control Organisation (CDSCO), has approved AstraZeneca...
Biocon Biologics gets USFDA nod for cancer drug Jobevne Ruchika Sharma10 April 2025 12:39 PM ISTBengaluru: Biocon Biologics Ltd (BBL), a subsidiary of Biocon Ltd, has announced that the U.S. Food and Drug Administration (U.S. FDA) has...
Shilpa Biologicals, mAbTree Biologics ink pact for cancer drug Ruchika Sharma18 March 2025 12:30 PM ISTKarnataka: Shilpa Biologicals Pvt Ltd., a fully owned subsidiary of Shilpa Medicare Limited has signed an exclusive partnership...
Merck injected version of Keytruda faces possible patent challenge: Report Ruchika Sharma6 March 2025 5:06 PM ISTMerck's newly developed injected version of its blockbuster cancer drug, Keytruda, may be at the center of a potential patent dispute,...
US Market Pressure Weighs on Glenmark's Q3 Earnings, Profit Below Estimates Farhat Nasim15 Feb 2025 3:35 PM ISTGlenmark reported a consolidated net profit of 3.48 billion rupees (USD 40.15 million) for the quarter ended December 31.
Exempt cancer, rare-disease drugs from tax in budget: Biocon Chief urges govt Ruchika Sharma20 Jan 2025 1:06 PM ISTKiran Mazumdar-Shaw, Chairperson of Biocon, has urged the government to remove tax on medicines used to treat cancer, chronic illnesses, and rare...
Drug Raid Uncovers Rs 6.60 Crore Worth of Spurious Medicines in Kolkata Dr. Bhumika Maikhuri2 Jan 2025 5:45 PM ISTIn a joint investigation conducted by the Central Drugs Standard Control Organization (CDSCO), East Zone, and the Drugs Control Directorate, West...
